Postmenopausal hormone replacement therapy: How could we have been so wrong?

Annals of Internal Medicine

Volumn 137, Issue 4, 2002, Pages 290-

  Laine, Christine ^a  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ALZHEIMER DISEASE; BREAST CANCER; CLINICAL TRIAL; COLORECTAL CANCER; CORONARY ARTERY DISEASE; CORONARY RISK; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; LUNG EMBOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; SHORT SURVEY; SOCIOECONOMICS; STROKE;

EID: 0037143534     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-4-200208200-00015     Document Type: Short Survey

References (6)

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial
2. Use of hormone replacement therapy by postmenopausal women in the United States
3. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
4. The protective effects of estrogen on the cardiovascular system
5. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease